Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioRestorative Therapies (BRTX) Equity Ratio (2016 - 2025)

BioRestorative Therapies (BRTX) has disclosed Equity Ratio for 15 consecutive years, with 0.39 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Equity Ratio fell 42.95% year-over-year to 0.39, compared with a TTM value of 0.39 through Sep 2025, down 42.95%, and an annual FY2024 reading of 0.69, down 12.42% over the prior year.
  • Equity Ratio was 0.39 for Q3 2025 at BioRestorative Therapies, down from 0.57 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.81 in Q1 2024 and bottomed at 2.24 in Q3 2021.
  • Average Equity Ratio over 5 years is 0.26, with a median of 0.57 recorded in 2025.
  • The sharpest move saw Equity Ratio skyrocketed 256.78% in 2021, then crashed 68.19% in 2023.
  • Year by year, Equity Ratio stood at 0.48 in 2021, then surged by 30.38% to 0.63 in 2022, then grew by 26.69% to 0.79 in 2023, then decreased by 12.42% to 0.69 in 2024, then crashed by 43.7% to 0.39 in 2025.
  • Business Quant data shows Equity Ratio for BRTX at 0.39 in Q3 2025, 0.57 in Q2 2025, and 0.6 in Q1 2025.